In some forms of human tumors, TAMs have also been reported to show defective release of IL-12 [197], and to increase secretion of anti-inflammatory cytokines such as IL-10 [197, 198], to influence tumor progression via the promotion of tumor vascularization, growth, survival, and metastasis [182, 192, 199, 200]. Here, IL10 is linked to neoplasm.